Naveglitazar
Naveglitazar (LY 519818) is a peroxisome proliferator-activated receptor (PPAR) modulator investigated for type 2 diabetes. It has been studied in phase II clinical trials and utilized in preclinical research to examine its metabolic effects in both in vitro and in vivo models.
Product Specifications
CAS Number
476436-68-7
Field of Research
Metabolism Research, Molecular Biology
Smiles
O (C1=CC=C (OCCCOC2=CC=C (C[C@@H] (C (O) =O) OC) C=C2) C=C1) C3=CC=CC=C3
Molecular Formula
C25H26O6
Molecular Weight
422.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1342611-01 0.02 mg (E-Coli)
Recombinant Loligo vulgaris Diisopropyl-fluorophosphatase
Sign In for Pricing
View Details MBS1342611-02 0.02 mg (Yeast)
Recombinant Loligo vulgaris Diisopropyl-fluorophosphatase
Sign In for Pricing
View Details MBS1342611-03 0.1 mg (E-Coli)
Recombinant Loligo vulgaris Diisopropyl-fluorophosphatase
Sign In for Pricing
View Details MBS1342611-04 0.1 mg (Yeast)
Recombinant Loligo vulgaris Diisopropyl-fluorophosphatase
Sign In for Pricing
View Details MBS1342611-05 0.02 mg (Baculovirus)
Recombinant Loligo vulgaris Diisopropyl-fluorophosphatase
Sign In for Pricing
View Details MBS1342611-06 0.02 mg (Mammalian-Cell)
Recombinant Loligo vulgaris Diisopropyl-fluorophosphatase
Sign In for Pricing
View Details